When describing the drug "Dalargin", reviews of specialists indicate its special characteristics. The drug is synthetic, includes an opioid ring, but does not have characteristic opioid effects - it does not provoke addiction and does not cause euphoria. Along with this, the drug "Dalargin" has an effect on blood vessels, improves blood flow. These properties of the drug allow its use in the complex treatment of pathologies associated with impaired blood patency in the arteries of the lower extremities. Thus, the drug “Dalargin” is a supplement to the treatment of pain and spastic syndrome in patients suffering from the consequences of spinal cord injury. In addition, the drug is able to have a positive effect on the mental state of patients with alcoholism.
The main indications for taking the drug “Dalargin” are instructions for use, called duodenal ulcers and stomach ulcers in the acute stage, acute pancreatitis.
The drug is a protein molecule (synthetic). Its administration contributes to the suppression of enzymatic cleavage, activates the regeneration of ulcerative lesions located both in the duodenum and in the gastric wall. With regular use of the drug "Dalargin" there is a decrease in the acidity of the gastric juice due to antisecretone activity, expressed moderately.
The medication is prescribed to suppress the production of enzymes in the pancreas in response to irritants (food). The drug "Dalargin" instructions for use are recommended for use in lesions of the organ itself (pancreas). In the course of studies, the ability of the drug to limit areas of necrosis was established, contributing to their replacement with a full-fledged tissue (healthy).
Describing the properties of the drug "Dalargin", the instructions for use indicate the ability to slightly hypotensive effect. This allows the use of the medication for patients suffering from high blood pressure.
The drug "Dalargin." Instructions: contraindications
Do not prescribe a drug for intolerance to components, low blood pressure (arterial hypotension), acute diseases of an infectious nature. Due to the lack of adequate data on the safety and effectiveness of pregnant and lactating women, the Dalargin medication is not prescribed during gestation and lactation.
Taking the drug can provoke hypotension (lowering blood pressure), allergies.
Clinical practice does not describe cases of drug overdose.
The drug "Dalargin" is available in powder form for injection. The introduction is carried out intravenously or intramuscularly. Preparation of the solution must be carried out immediately before injection. The powder from one ampoule is dissolved in one milliliter of saline.
With exacerbation of ulcers in the duodenum and stomach, a single dosage of 1-2 mg, 5 mg - the maximum dose per day. The duration of therapy is from three to four weeks. The total amount of the drug for the entire course is from thirty to fifty milligrams.
In acute pancreatitis, intravenous administration of two milligrams is recommended once, then the dosage is increased to five milligrams, once or twice a day. Therapy is continued from four to six days.
In pancreatic necrosis, injections are carried out intravenously at five milligrams every six to eight hours. Continue therapy with the drug "Dalargin"; instructions for use recommends from two to six days. The duration of the course depends on how long it takes to alleviate the condition.